133 related articles for article (PubMed ID: 38564511)
1. Retraction: Overexpression of SATB1 Is Associated with Biologic Behavior in Human Renal Cell Carcinoma.
PLOS ONE Editors
PLoS One; 2024; 19(4):e0301571. PubMed ID: 38564511
[No Abstract] [Full Text] [Related]
2. Overexpression of SATB1 is associated with biologic behavior in human renal cell carcinoma.
Cheng C; Wan F; Liu L; Zeng F; Xing S; Wu X; Chen X; Zhu Z
PLoS One; 2014; 9(5):e97406. PubMed ID: 24835085
[TBL] [Abstract][Full Text] [Related]
3. SATB1 is Down-regulated in Clear Cell Renal Cell Carcinoma and Correlates with miR-21-5p Overexpression and Poor Prognosis.
Kowalczyk AE; Krazinski BE; Godlewski J; Grzegrzolka J; Kiewisz J; Kwiatkowski P; Sliwinska-Jewsiewicka A; Dziegiel P; Kmiec Z
Cancer Genomics Proteomics; 2016; 13(3):209-17. PubMed ID: 27107063
[TBL] [Abstract][Full Text] [Related]
4. SATB1 expression is associated with biologic behavior in colorectal carcinoma in vitro and in vivo.
Zhang J; Zhang B; Zhang X; Sun Y; Wei X; McNutt MA; Lu S; Liu Y; Zhang D; Wang M; Lin Z; Niu N
PLoS One; 2013; 8(1):e47902. PubMed ID: 23326301
[TBL] [Abstract][Full Text] [Related]
5. Aberrant SATB1 expression is associated with Epstein-Barr virus infection, metastasis and survival in human nasopharyngeal cells and endemic nasopharyngeal carcinoma.
Deng YF; Zhou DN; Pan ZY; Yin P
Int J Clin Exp Pathol; 2014; 7(5):2454-61. PubMed ID: 24966956
[TBL] [Abstract][Full Text] [Related]
6. Triptolide inhibits esophageal squamous cell carcinoma progression by regulating the circNOX4/miR-153-3p/SATB1 signaling pathway.
Liang H; Che W; Peng F; Chen H; Xie X; Wu B
Thorac Cancer; 2024 Mar; 15(7):538-549. PubMed ID: 38268309
[TBL] [Abstract][Full Text] [Related]
7. [Expression of SATB1 in hepatocellular carcinoma cell lines with different invasive capacities].
Li G; Yang D; Li X; Zhong K; Liu X; Bi M; Liu Y; Liao X; Lin L
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Jun; 32(7):986-90, 994. PubMed ID: 22820583
[TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNA DRAIC acts as a microRNA-122 sponge to facilitate nasopharyngeal carcinoma cell proliferation, migration and invasion via regulating SATB1.
Liao B; Wang Z; Zhu Y; Wang M; Liu Y
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3585-3597. PubMed ID: 31497998
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of SATB1 in laryngeal squamous cell carcinoma.
Zhao XD; Ji WY; Zhang W; He LX; Yang J; Liang HJ; Wang LL
ORL J Otorhinolaryngol Relat Spec; 2010; 72(1):1-5. PubMed ID: 20110741
[TBL] [Abstract][Full Text] [Related]
10. Over-expression of the special AT rich sequence binding protein 1 (SATB1) promotes the progression of nasopharyngeal carcinoma: association with EBV LMP-1 expression.
Shen Z; Zeng Y; Guo J; Wu Y; Jiang X; Ding R; Wu C; Li R; Luo B; Zeng C; Jiang H; Jie W
J Transl Med; 2013 Sep; 11():217. PubMed ID: 24047082
[TBL] [Abstract][Full Text] [Related]
11. Loss of special AT-rich binding protein 1 expression is a marker of poor survival in lung cancer.
Selinger CI; Cooper WA; Al-Sohaily S; Mladenova DN; Pangon L; Kennedy CW; McCaughan BC; Stirzaker C; Kohonen-Corish MR
J Thorac Oncol; 2011 Jul; 6(7):1179-89. PubMed ID: 21597389
[TBL] [Abstract][Full Text] [Related]
12. SATB1 overexpression regulates the development and progression in bladder cancer through EMT.
Wan F; Cheng C; Wang Z; Xiao X; Zeng H; Xing S; Chen X; Wang J; Li S; Zhang Y; Xiang W; Zhu Z; Johnson C; Zhu Z
PLoS One; 2015; 10(2):e0117518. PubMed ID: 25706386
[TBL] [Abstract][Full Text] [Related]
13. SATB1 Knockdown Inhibits Proliferation and Invasion and Decreases Chemoradiation Resistance in Nasopharyngeal Carcinoma Cells by Reversing EMT and Suppressing MMP-9.
Zhou D; Ye C; Pan Z; Deng Y
Int J Med Sci; 2021; 18(1):42-52. PubMed ID: 33390772
[No Abstract] [Full Text] [Related]
14. MicroRNA-495 suppresses human renal cell carcinoma malignancy by targeting SATB1.
Lv C; Bai Z; Liu Z; Luo P; Zhang J
Am J Transl Res; 2015; 7(10):1992-9. PubMed ID: 26692942
[TBL] [Abstract][Full Text] [Related]
15. Correlation of SATB1 overexpression with the progression of human rectal cancer.
Meng WJ; Yan H; Zhou B; Zhang W; Kong XH; Wang R; Zhan L; Li Y; Zhou ZG; Sun XF
Int J Colorectal Dis; 2012 Feb; 27(2):143-50. PubMed ID: 21870058
[TBL] [Abstract][Full Text] [Related]
16. Multiple effects of the special AT-rich binding protein 1 (SATB1) in colon carcinoma.
Frömberg A; Rabe M; Aigner A
Int J Cancer; 2014 Dec; 135(11):2537-46. PubMed ID: 24729451
[TBL] [Abstract][Full Text] [Related]
17. SATB1 Level Correlates with Ki-67 Expression and Is a Positive Prognostic Factor in Non-small Cell Lung Carcinoma.
Glatzel-Plucinska N; Piotrowska A; Grzegrzolka J; Olbromski M; Rzechonek A; Dziegiel P; Podhorska-Okolow M
Anticancer Res; 2018 Feb; 38(2):723-736. PubMed ID: 29374696
[TBL] [Abstract][Full Text] [Related]
18. Expression and biological roles of SATB1 in human bladder cancer.
Han B; Luan L; Xu Z; Wu B
Tumour Biol; 2013 Oct; 34(5):2943-9. PubMed ID: 23696028
[TBL] [Abstract][Full Text] [Related]
19. Silencing SATB1 influences cell invasion, migration, proliferation, and drug resistance in nasopharyngeal carcinoma.
Ye CS; Zhou DN; Yang QQ; Deng YF
Int J Clin Exp Pathol; 2014; 7(3):914-22. PubMed ID: 24696710
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of ubiquitin carboxy‑terminal hydrolase 47 (USP47) in papillary thyroid carcinoma ex vivo and reduction of tumor cell malignant behaviors after USP47 knockdown by stabilizing SATB1 expression in vitro.
Luo G; Zhang L; Wu W; Zhang L; Lin J; Shi H; Wu X; Yu Y; Qiu W; Chen J; Ding H; Chen X
Oncol Lett; 2023 Sep; 26(3):370. PubMed ID: 37564825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
